Patterns of cytopathology and lysosomal enzyme release in poliovirus-infected HEp-2 cells treated with either 2-(alpha-hydroxybenzyl)-benzimidazole or guanidine HCl.
D000998:Antiviral Agents / Q000494:pharmacology; D001562:Benzimidazoles / Q000494:pharmacology*; D002277:Carcinoma; D002460:Cell Line; D003588:Cytopathogenic Effect, Viral; D005696:Galactosidases / Q000378:metabolism; D005966:Glucuronidase / Q000378:metabolism; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D007822:Laryngeal Neoplasms; D008247:Lysosomes / Q000201:enzymology*; D017955:Poliovirus / Q000187:drug effects*; D013429:Sulfatases / Q000378:metabolism; D013997:Time Factors; D014764:Viral Proteins / Q000096:biosynthesis; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D001562:Benzimidazoles; D006146:Guanidines; D014764:Viral Proteins; D013429:Sulfatases; D005696:Galactosidases; D005966:Glucuronidase